Related Experiment Videos
Kinetically-based multiple drug treatment for advanced head and neck cancer
British Medical Journal
|July 5, 1975
Summary
Advanced head and neck cancer patients showed significant tumor reduction with multiple drug chemotherapy. Early intervention, ideally alongside surgery or radiotherapy, is recommended for better outcomes in these challenging carcinomas.
Area of Science:
- Oncology
- Medical Research
Background:
- Head and neck cancers represent a significant clinical challenge.
- Advanced stages often require aggressive treatment modalities.
Purpose of the Study:
- To evaluate the efficacy of a multiple drug regimen in patients with advanced head and neck carcinomas.
- To determine the optimal timing for initiating combination chemotherapy.
Main Methods:
- A cohort of 36 patients with advanced head and neck carcinomas received a multiple drug chemotherapy regimen.
- Tumor response was assessed in 24 assessable patients.
Main Results:
- Significant tumor regression (>50%) was observed in 19 out of 24 assessable patients.
- One patient experienced a 25% tumor regression, while four showed no response.
Conclusions:
- Multiple drug chemotherapy demonstrates considerable efficacy in advanced head and neck cancers.
- Early administration of combination chemotherapy, as an adjuvant to surgery or radiotherapy, is strongly suggested.